Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Michael J Fox Foundation backs wearable device trial

Partners with chip manufacturer Intel and Cynapsus Therapeutics on Parkinson's study

- PMLiVE

Natasha Giordano joins PLx Pharma

She replaces Ronald Zimmerman as president and chief executive officer

- PMLiVE

Valeant names Schiller interim CEO as Pearson battles illness

Former CFO fills in and Ingram is appointed interim chairman of the board

- PMLiVE

Lucid Group US: moving on up!

New premises for Lucid Group US

Lucid Group Communications Limited

- PMLiVE

Portland appoints Dr Jane Brearley as head of health

She assumes sole responsibility following joint-head Louise Fish’s departure

- PMLiVE

Baxalta and CTI complete filing for Jakafi rival in US

Myelofibrosis candidate pacritinib aiming for accelerated approval

Novaliq GmbH appoints Friedrich von Bolen as chairman

And Gerald Cagle joins as a member of the supervisory board

Roche nominates Dr Claudia Süssmuth Dyckerhoff to board

She is set to replace Professor Dr Beatrice Weder di Mauro

- PMLiVE

Syndax teams with Merck/Pfizer on immuno-oncology combo

Oral cancer drug entinostat to test with avelumab

Gilead Sciences

Priority FDA review for new Gilead HCV combination therapy

Sovaldi/velpatasvir combination could be approved in the US by summer 2016

- PMLiVE

FDA approvals hit 19-year high

US regulator cleared 45 NMEs in 2015, its highest tally since 1996

- PMLiVE

Sanofi abandons inhaled insulin pact with Mannkind

Poor sales prompt return of Afrezza rights less than a year after its launch

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links